One research group at the Clemson University Eukaryotic Pathogens Innovation Center has identified a compound that inhibits a key enzyme that brain-eating amoebas need to live, while a second ...
Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...
Tonix Pharma receives US patent covering the intranasal delivery of Tosymra to treat migraine: Chatham, New Jersey Saturday, September 21, 2024, 13:00 Hrs [IST] Tonix Pharmaceutic ...
Alzheimer’s disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need ...